News » News

News

Sunflower Therapeutics Awarded $8.1M Grant

Sunflower Therapeutics, a public benefit corporation focused on improving access to biologic medicines for patients worldwide, announced that it was granted a second phase of funding to support an existing award made by the Bill & Melinda Gates Foundation to further the foundation’s charitable purpose of improving global health. This award will support the development of a laboratory-scale, deployable manufacturing system and will culminate in the demonstrated production of a protein subunit for a COVID-19 vaccine candidate later this year.

read more

US DOD Awards $10.5M Contract To Sunflower Therapeutics

Sunflower Therapeutics, a public benefit corporation focused on efficient manufacturing for proteins, announced that it has been awarded a $5.7 million extension of an existing contract with the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) for the purpose of developing a Biologics on Demand (BOD) manufacturing prototype for recombinant protein-based medical countermeasures (MCMs).

read more

How to make biopharmaceuticals quickly in small batches | NIH Director’s Blog

Today, vaccines and other protein-based biologic drugs are typically made in large, dedicated manufacturing facilities. But that doesn’t always fit the need, and it could one day change. A team of researchers has engineered a miniaturized biopharmaceutical “factory” that could fit on a dining room table and produce hundreds to thousands of doses of a needed treatment in about three days.

read more

Fast, nimble, and on demand: the pursuit of a new way to mass produce medicines | STAT

Today there’s essentially one model for drug production: make as much as possible. But J. Christopher Love, a professor of chemical engineering at the Massachusetts Institute of Technology, has spent the last five years pursuing a different vision: a desktop drug manufacturing process that would be fast and nimble enough to help combat a small disease outbreak, treat an unusual cancer, or replace a rare enzyme.

read more